Trial Profile
A double blinded, multicentre, randomised control trial comparing the effectiveness of the Paclitaxel drug eluting angioplasty balloon with an ordinary angioplasty balloon in preventing restenosis and re-intervention in the treatment of recurrent autogenous hemodialysis fistula stenoses in the hemodialysis population of three participating Australian Hospitals.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial occlusive disorders
- Focus Therapeutic Use
- Acronyms DEB in AVF
- 05 Jul 2018 New trial record